Furthermore, CD63 exhibited significantly higher expression levels in the malignant cell clusters of immune cells and demonstrated a strong correlation with glycolytic genes, such as LDHA and LDHB, in tumor cells (Figures 1F–J). The gene discussed is CD63; the disease is neoplasm.